Aspire Biopharma Enters Material Definitive Agreement
Ticker: ASBPW · Form: 8-K · Filed: Apr 30, 2025 · CIK: 1847345
Sentiment: neutral
Topics: material-definitive-agreement, corporate-actions
TL;DR
Aspire Biopharma just signed a big deal, filing an 8-K on it.
AI Summary
Aspire Biopharma Holdings, Inc. entered into a material definitive agreement on April 24, 2025. The filing also includes financial statements and exhibits related to this agreement. The company was formerly known as PowerUp Acquisition Corp. and PowsedrUp Acquisition Corp.
Why It Matters
This filing indicates a significant new development for Aspire Biopharma, potentially impacting its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided text.
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Registrant
- PowerUp Acquisition Corp. (company) — Former Company Name
- PowsedrUp Acquisition Corp. (company) — Former Company Name
- April 24, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Aspire Biopharma Holdings, Inc.?
The provided text states that Aspire Biopharma Holdings, Inc. entered into a material definitive agreement on April 24, 2025, but does not specify the details of the agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 24, 2025.
What were the former names of Aspire Biopharma Holdings, Inc.?
Aspire Biopharma Holdings, Inc. was formerly known as PowerUp Acquisition Corp. and PowsedrUp Acquisition Corp.
What is the Standard Industrial Classification (SIC) code for Aspire Biopharma Holdings, Inc.?
The SIC code for Aspire Biopharma Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
In which state was Aspire Biopharma Holdings, Inc. incorporated?
Aspire Biopharma Holdings, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding Aspire Biopharma Holdings, Inc. (ASBPW).